OneMedNet, Onco-Innovations and Inka Health Collaborate to Accelerate Oncology Drug Development with Real-World Data and AI

Wednesday, Apr 1, 2026 8:57 am ET1min read
ONMD--
PLTR--

OneMedNet Corporation has collaborated with Onco-Innovations and Inka Health to accelerate potential for oncology drug development using real-world data and AI. The agreement provides access to OneMedNet's iRWD platform, powered by Palantir Foundry, for real-world oncology data. The collaboration aims to reduce clinical and regulatory risk and strengthen evidence generation for Onco-Innovations' PNKP Inhibitor Technology targeting PTEN/SHP1-deficient cancers.

OneMedNet, Onco-Innovations and Inka Health Collaborate to Accelerate Oncology Drug Development with Real-World Data and AI

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet